{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:52:10Z","timestamp":1763358730212,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2016\/424"],"award-info":[{"award-number":["CAN 2016\/424"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics & Chromatin"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13072-018-0252-7","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T05:39:15Z","timestamp":1546839555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"12","author":[{"given":"Sara","family":"Wernig-Zorc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh Pratap","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep Kumar","family":"Kopparapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Bemark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hallgerdur Lind","family":"Kristjansdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Ola","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrasekhar","family":"Kanduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-4779","authenticated-orcid":false,"given":"Meena","family":"Kanduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"issue":"9","key":"252_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrg887","volume":"3","author":"E Li","year":"2002","unstructured":"Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002;3(9):662\u201373.","journal-title":"Nat Rev Genet"},{"issue":"5618","key":"252_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1083557","volume":"300","author":"A Eden","year":"2003","unstructured":"Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003;300(5618):455.","journal-title":"Science"},{"issue":"6","key":"252_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.drup.2003.10.002","volume":"6","author":"M Szyf","year":"2003","unstructured":"Szyf M. DNA methylation and cancer therapy. Drug Resist Updat. 2003;6(6):341\u201353.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"252_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2009-07-232868","volume":"115","author":"M Kanduri","year":"2010","unstructured":"Kanduri M, Cahill N, Goransson H, Enstrom C, Ryan F, Isaksson A, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood. 2010;115(2):296\u2013305.","journal-title":"Blood"},{"issue":"7","key":"252_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4161\/epi.24947","volume":"8","author":"S Martinelli","year":"2013","unstructured":"Martinelli S, Kanduri M, Maffei R, Fiorcari S, Bulgarelli J, Marasca R, et al. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia. Epigenetics. 2013;8(7):720\u20139.","journal-title":"Epigenetics"},{"issue":"5","key":"252_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/15592294.2016.1164375","volume":"11","author":"PK Kopparapu","year":"2016","unstructured":"Kopparapu PK, Bhoi S, Mansouri L, Arabanian LS, Plevova K, Pospisilova S, et al. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: impact on EZH2 expression. Epigenetics. 2016;11(5):335\u201343.","journal-title":"Epigenetics"},{"issue":"3","key":"252_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4161\/epi.6.3.14038","volume":"6","author":"L Irving","year":"2011","unstructured":"Irving L, Mainou-Fowler T, Parker A, Ibbotson RE, Oscier DG, Strathdee G. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics. 2011;6(3):300\u20136.","journal-title":"Epigenetics"},{"issue":"3","key":"252_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet. 2016;48(3):253\u201364.","journal-title":"Nat Genet"},{"issue":"11","key":"252_CR9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236\u201342.","journal-title":"Nat Genet"},{"issue":"11","key":"252_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.14348\/molcells.2015.0294","volume":"38","author":"JA Han","year":"2015","unstructured":"Han JA, An J, Ko M. Functions of TET proteins in hematopoietic transformation. Mol Cells. 2015;38(11):925\u201335.","journal-title":"Mol Cells"},{"issue":"11","key":"252_CR11","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1242\/dev.070771","volume":"139","author":"L Tan","year":"2012","unstructured":"Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development. 2012;139(11):1895\u2013902.","journal-title":"Development"},{"issue":"5","key":"252_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ygeno.2014.08.015","volume":"104","author":"MA Hahn","year":"2014","unstructured":"Hahn MA, Szabo PE, Pfeifer GP. 5-Hydroxymethylcytosine: a stable or transient DNA modification? Genomics. 2014;104(5):314\u201323.","journal-title":"Genomics"},{"issue":"4","key":"252_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1349-7006.2012.02213.x","volume":"103","author":"Y Kudo","year":"2012","unstructured":"Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci. 2012;103(4):670\u20136.","journal-title":"Cancer Sci"},{"issue":"22","key":"252_CR14","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, et al. Mutation in TET2 in myeloid cancers. New Engl J Med. 2009;360(22):2289\u2013301.","journal-title":"New Engl J Med"},{"issue":"6","key":"252_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135\u201346.","journal-title":"Cell"},{"issue":"5","key":"252_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/onc.2012.67","volume":"32","author":"H Yang","year":"2013","unstructured":"Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663\u20139.","journal-title":"Oncogene"},{"key":"252_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13148-016-0195-4","volume":"8","author":"SN Kamdar","year":"2016","unstructured":"Kamdar SN, Ho LT, Kron KJ, Isserlin R, van der Kwast T, Zlotta AR, et al. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis. Clin Epigenet. 2016;8:32.","journal-title":"Clin Epigenet"},{"issue":"10","key":"252_CR18","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-15-1910","volume":"76","author":"JP Thomson","year":"2016","unstructured":"Thomson JP, Ottaviano R, Unterberger EB, Lempiainen H, Muller A, Terranova R, et al. Loss of Tet1-associated 5-hydroxymethylcytosine is concomitant with aberrant promoter hypermethylation in liver cancer. Cancer Res. 2016;76(10):3097\u2013108.","journal-title":"Cancer Res"},{"issue":"1","key":"252_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2015.150","volume":"26","author":"K Chen","year":"2016","unstructured":"Chen K, Zhang J, Guo Z, Ma Q, Xu Z, Zhou Y, et al. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer. Cell Res. 2016;26(1):103\u201318.","journal-title":"Cell Res"},{"issue":"4","key":"252_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00404-015-3704-3","volume":"292","author":"LY Zhang","year":"2015","unstructured":"Zhang LY, Li PL, Wang TZ, Zhang XC. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer. Arch Gynecol Obstet. 2015;292(4):891\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"252_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18632\/oncotarget.316","volume":"2","author":"MC Haffner","year":"2011","unstructured":"Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627\u201337.","journal-title":"Oncotarget"},{"issue":"2","key":"252_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.celrep.2013.01.011","volume":"3","author":"MA Hahn","year":"2013","unstructured":"Hahn MA, Qiu R, Wu X, Li AX, Zhang H, Wang J, et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep. 2013;3(2):291\u2013300.","journal-title":"Cell Rep"},{"issue":"7","key":"252_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SM Langemeijer","year":"2009","unstructured":"Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838\u201342.","journal-title":"Nat Genet"},{"issue":"1","key":"252_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114(1):144\u20137.","journal-title":"Blood"},{"issue":"7","key":"252_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1182\/blood-2013-08-518514","volume":"124","author":"LI Kroeze","year":"2014","unstructured":"Kroeze LI, Aslanyan MG, van Rooij A, Koorenhof-Scheele TN, Massop M, Carell T, et al. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation. Blood. 2014;124(7):1110\u20138.","journal-title":"Blood"},{"key":"252_CR26","doi-asserted-by":"publisher","first-page":"814294","DOI":"10.1155\/2014\/814294","volume":"2014","author":"M Hernandez-Sanchez","year":"2014","unstructured":"Hernandez-Sanchez M, Rodriguez AE, Kohlmann A, Benito R, Garcia JL, Risueno A, et al. TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations. Biomed Res Int. 2014;2014:814294.","journal-title":"Biomed Res Int"},{"issue":"7","key":"252_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ng.3291","volume":"47","author":"M Kulis","year":"2015","unstructured":"Kulis M, Merkel A, Heath S, Queiros AC, Schuyler RP, Castellano G, et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat Genet. 2015;47(7):746\u201356.","journal-title":"Nat Genet"},{"issue":"8","key":"252_CR28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood.V80.8.2074.bloodjournal8082074","volume":"80","author":"J Wahlfors","year":"1992","unstructured":"Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, Janne J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood. 1992;80(8):2074\u201380.","journal-title":"Blood"},{"issue":"2","key":"252_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4161\/epi.6.2.13528","volume":"6","author":"S Fabris","year":"2011","unstructured":"Fabris S, Bollati V, Agnelli L, Morabito F, Motta V, Cutrona G, et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics. 2011;6(2):188\u201394.","journal-title":"Epigenetics"},{"key":"252_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13148-016-0274-6","volume":"8","author":"S Subhash","year":"2016","unstructured":"Subhash S, Andersson PO, Kosalai ST, Kanduri C, Kanduri M. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Clin Epigenet. 2016;8:106.","journal-title":"Clin Epigenet"},{"issue":"12","key":"252_CR31","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1101\/gr.211854.116","volume":"26","author":"X Li","year":"2016","unstructured":"Li X, Liu Y, Salz T, Hansen KD, Feinberg A. Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver. Genomed Res. 2016;26(12):1730\u201341.","journal-title":"Genomed Res"},{"issue":"1","key":"252_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/art.38200","volume":"66","author":"SE Taylor","year":"2014","unstructured":"Taylor SE, Smeriglio P, Dhulipala L, Rath M, Bhutani N. A global increase in 5-hydroxymethylcytosine levels marks osteoarthritic chondrocytes. Arthr Rheumatol. 2014;66(1):90\u2013100.","journal-title":"Arthr Rheumatol"},{"issue":"1","key":"252_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4161\/onci.1.1.18400","volume":"1","author":"A Rosen","year":"2012","unstructured":"Rosen A, Bergh AC, Gogok P, Evaldsson C, Myhrinder AL, Hellqvist E, et al. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. Oncoimmunology. 2012;1(1):18\u201327.","journal-title":"Oncoimmunology"},{"issue":"2","key":"252_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D, et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leukemia Res. 1999;23(2):127\u201336.","journal-title":"Leukemia Res"},{"issue":"2","key":"252_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1101\/gr.152132.112","volume":"24","author":"PG Ferreira","year":"2014","unstructured":"Ferreira PG, Jares P, Rico D, Gomez-Lopez G, Martinez-Trillos A, Villamor N, et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 2014;24(2):212\u201326.","journal-title":"Genome Res"},{"issue":"7325","key":"252_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature. 2010;468(7325):839\u201343.","journal-title":"Nature"},{"issue":"9","key":"252_CR37","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1182\/blood-2010-12-324707","volume":"118","author":"E Pronier","year":"2011","unstructured":"Pronier E, Almire C, Mokrani H, Vasanthakumar A, Simon A, da Costa Reis Monte Mor B, et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood. 2011;118(9):2551\u20135.","journal-title":"Blood"},{"issue":"44","key":"252_CR38","doi-asserted-by":"publisher","first-page":"77595","DOI":"10.18632\/oncotarget.20668","volume":"8","author":"PK Kopparapu","year":"2017","unstructured":"Kopparapu PK, Abdelrazak Morsy MH, Kanduri C, Kanduri M. Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia. Oncotarget. 2017;8(44):77595\u2013608.","journal-title":"Oncotarget"},{"issue":"3","key":"252_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jbmr.2711","volume":"31","author":"SE Taylor","year":"2016","unstructured":"Taylor SE, Li YH, Smeriglio P, Rath M, Wong WH, Bhutani N. Stable 5-hydroxymethylcytosine (5hmC) Acquisition marks gene activation during chondrogenic differentiation. J Bone Miner Res. 2016;31(3):524\u201334.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"252_CR40","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI82890","volume":"126","author":"SN Crabben van der","year":"2016","unstructured":"van der Crabben SN, Hennus MP, McGregor GA, Ritter DI, Nagamani SC, Wells OS, et al. Destabilized SMC5\/6 complex leads to chromosome breakage syndrome with severe lung disease. J Clin Investig. 2016;126(8):2881\u201392.","journal-title":"J Clin Investig"},{"issue":"7","key":"252_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/NEN.0000000000000212","volume":"74","author":"E Draberova","year":"2015","unstructured":"Draberova E, D\u2019Agostino L, Caracciolo V, Sladkova V, Sulimenko T, Sulimenko V, et al. Overexpression and nucleolar localization of gamma-Tubulin small complex proteins GCP2 and GCP3 in glioblastoma. J Neuropathol Exp Neurol. 2015;74(7):723\u201342.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"252_CR42","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446\u201356.","journal-title":"Blood"},{"issue":"4","key":"252_CR43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7555\/JBR.29.20150035","volume":"29","author":"M Bemark","year":"2015","unstructured":"Bemark M. Translating transitions\u2014how to decipher peripheral human B cell development. J Biomed Res. 2015;29(4):264\u201384.","journal-title":"J Biomed Res"},{"issue":"3","key":"252_CR44","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.","journal-title":"Genome Biol"},{"issue":"9","key":"252_CR45","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.","journal-title":"Genome Biol"},{"issue":"4","key":"252_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576\u201389.","journal-title":"Mol Cell"}],"container-title":["Epigenetics & Chromatin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-018-0252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13072-018-0252-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-018-0252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:04:16Z","timestamp":1720904656000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-018-0252-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1186\/s13072-018-0252-7","relation":{},"ISSN":["1756-8935"],"issn-type":[{"type":"electronic","value":"1756-8935"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}